In an exclusive conversation with Fortune India, the executive chairperson of Biocon says India should immediately start mixing and matching existing vaccines to accelerate the vaccination drive.
India’s vaccine giant faces the huge social responsibility of supply into the domestic market and a contractual demand for export of vaccines to foreign countries.
Bharat Biotech, founded by Krishna Ella and his wife Suchitra, has been at the forefront of making vaccines for a while. Yet it took a global pandemic for the spotlight to shine on the company.
As India battles the second wave of Covid-19, which has caused havoc across the country, healthcare companies have come to the fore as lifesavers, to ensure the attack of the virus is countered.
In a big move, India has opened up Covid-19 vaccinations for all adults. However, the country is beset by severe vaccine shortage and other challenges. Will increasing the demand base work?
RDIF has tied up with nearly a dozen contract manufacturers with idle capacity to produce some 1.5 billion doses of Sputnik V annually, more than what Serum and Bharat Biotech will jointly produce.
For the International Women’s Day, we celebrate the 50 women who featured in our Most Powerful Women (MPW) in Business list for the year 2020. Here’s the editor’s letter from that issue.
As India starts the second phase of its Covid-19 vaccine deployment, the question on the viability of its supply chain network, and its cold storage capability, has become more pertinent than ever.
In an exclusive interview, U.K. Secretary of State for International Trade Elizabeth Truss talks about a potential Free Trade Agreement between India and the U.K., and further areas of collaboration.
